Chimerix, Inc. (CMRX)
Apr 21, 2025 - CMRX was delisted (reason: acquired by JAZZ)
8.54
-0.01 (-0.12%)
Inactive · Last trade price
on Apr 17, 2025
Chimerix Employees
Chimerix had 79 employees as of December 31, 2024. The number of employees increased by 7 or 9.72% compared to the previous year.
Employees
79
Change (1Y)
7
Growth (1Y)
9.72%
Revenue / Employee
$2,684
Profits / Employee
-$1,118,823
Market Cap
801.08M
Employees Chart
CMRX News
- 4 weeks ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 5 weeks ago - Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha
- 7 weeks ago - Chimerix Reports Fourth Quarter and Year End 2024 Financial Results - GlobeNewsWire
- 2 months ago - CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire
- 2 months ago - Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire
- 2 months ago - Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga
- 2 months ago - Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters